Lars Erik Bartels

7PUBLICATIONS
25CO-AUTHORS
Innate immunityInfectious diseasesPredictive and prognostic markersRespiratory diseasesSocial epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 26, 2024
COVID-19 Vaccination Before Initiating Rituximab Treatment Induces Strong Serological Response in Autoimmune Rheumatic Disease, Reducing Post-Pandemic Concerns About the Impact of Rituximab.

Christian Ammitzbøll, Marianne Kragh Thomsen, Lars Erik Bartels

|Jul 06, 2023
Outcomes following SARS-CoV-2 infection in individuals with and without inflammatory rheumatic diseases: a Danish nationwide cohort study.

Annemarie Lyng Lyng Svensson, Hanne-Dorthe Emborg, Lars Erik Bartels

|Mar 02, 2022
Time Since Rituximab Treatment Is Essential for Developing a Humoral Response to COVID-19 mRNA Vaccines in Patients With Rheumatic Diseases.

Anne Troldborg, Marianne Kragh Thomsen, Lars Erik Bartels

|Sep 03, 2021
Local and systemic reactogenicity of COVID-19 vaccine BNT162b2 in patients with systemic lupus erythematosus and rheumatoid arthritis.

Lars Erik Bartels, Christian Ammitzbøll, Jakob Bøgh Andersen

|Jul 17, 2021
Impaired Antibody Response to the BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine in Patients With Systemic Lupus Erythematosus and Rheumatoid Arthritis.

Christian Ammitzbøll, Lars Erik Bartels, Jakob Bøgh Andersen

|Dec 06, 2019
A positive Helicobacter pylori test is associated with low spondylarthritis incidence in a Danish historical cohort study.

Lars E Bartels, Alma B Pedersen, Nickolaj R Kristensen

Pageof 2

Frequent Collaborators

4 joint publications

Christian Ammitzbøll

4 joint publications

Marianne Kragh Thomsen

4 joint publications

Christian Erikstrup

4 joint publications

Ellen-Margrethe Hauge